Literature DB >> 19111429

Psychoeducation with patients at-risk for schizophrenia--an exploratory pilot study.

Marta Hauser1, Marion Lautenschlager, Yehonala Gudlowski, Seza Ozgürdal, Henning Witthaus, Andreas Bechdolf, Josef Bäuml, Andreas Heinz, Georg Juckel.   

Abstract

OBJECTIVE: To introduce a psychoeducational program for patients of at-risk mental state and its preliminary evaluation.
METHODS: The psychoeducational program was designed as a purely informative intervention and consisted of seven 1-h sessions. Sixteen at-risk mental state patients (mean age 26+/-4.9 years, 12 males/4 females, mean score on prodromal psychopathology (Bonn Scale for Assessment of predictive Basis Symptoms [BSABS-P] 18.6+/-13.3) were investigated.
RESULTS: Comparisons of means before and after psychoeducation showed a significant reduction in psychopathology and fatalistic LoC as well as an improvement in knowledge, global functioning and various areas of QoL. A qualitative evaluation of the psychoeducational program also showed advantages from patients' perspectives.
CONCLUSIONS: This study provides empirical evidence for benefits of psychoeducation with patients of at-risk mental state for schizophrenia but is exploratory and has some limitations, e.g. the small sample size. Therefore the results have to be replicated in a randomized controlled trial in order to be able to demonstrate conclusively the effectiveness of psychoeducation in the pre-psychotic phase. PRACTICE IMPLICATIONS: Results from this preliminary study suggest that psychoeducation is a promising intervention for patients of at-risk mental state for schizophrenia, and therefore worthy of more investigations.

Entities:  

Mesh:

Year:  2008        PMID: 19111429     DOI: 10.1016/j.pec.2008.11.003

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  5 in total

1.  [Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Con].

Authors:  A Bechdolf; S Laier; M Kallenbach; A Biester; K Leopold
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

Review 2.  Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

Authors:  Christoph U Correll; Marta Hauser; Andrea M Auther; Barbara A Cornblatt
Journal:  J Child Psychol Psychiatry       Date:  2010-02-26       Impact factor: 8.982

3.  Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions.

Authors:  Gabriel Gerlinger; Marta Hauser; Marc De Hert; Kathleen Lacluyse; Martien Wampers; Christoph U Correll
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

Review 4.  Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers.

Authors:  Alicia O'Cathain; Pat Hoddinott; Simon Lewin; Kate J Thomas; Bridget Young; Joy Adamson; Yvonne Jfm Jansen; Nicola Mills; Graham Moore; Jenny L Donovan
Journal:  Pilot Feasibility Stud       Date:  2015-09-07

5.  Effectiveness and acceptability of myo-inositol nutritional supplement in the prevention of gestational diabetes (EMmY): a protocol for a randomised, placebo-controlled, double-blind pilot trial.

Authors:  Chiamaka Esther Amaefule; Zoe Drymoussi; Julie Dodds; Lorna Sweeney; Elena Pizzo; Jahnavi Daru; John Robson; Lucilla Poston; Asma Khalil; Jenny Myers; Angela Harden; Graham A Hitman; Khalid Khan; Javier Zamora; Mohammed S B Huda; Shakila Thangaratinam
Journal:  BMJ Open       Date:  2018-09-24       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.